KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Shares Outstanding (Weighted Average) (2019 - 2025)

Ginkgo Bioworks Holdings filings provide 7 years of Shares Outstanding (Weighted Average) readings, the most recent being $55.5 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 6.87% to $55.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $55.5 million, a 6.87% increase, with the full-year FY2025 number at $55.5 million, up 6.87% from a year prior.
  • Shares Outstanding (Weighted Average) hit $55.5 million in Q4 2025 for Ginkgo Bioworks Holdings, roughly flat from $55.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.9 billion in Q2 2023 to a low of $1.6 million in Q1 2022.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $55.2 million (2025), compared with a mean of $645.7 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 99.88% in 2022 and later skyrocketed 119026.78% in 2023.
  • Ginkgo Bioworks Holdings' Shares Outstanding (Weighted Average) stood at $1.4 billion in 2021, then plummeted by 96.91% to $42.0 million in 2022, then increased by 15.8% to $48.6 million in 2023, then rose by 6.76% to $51.9 million in 2024, then rose by 6.87% to $55.5 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $55.5 million (Q4 2025), $55.6 million (Q3 2025), and $54.9 million (Q2 2025) per Business Quant data.